bioXXmed AG (FRA:T5O0)
0.0500
+0.0280 (127.27%)
At close: Jan 2, 2026
bioXXmed AG Market Cap
bioXXmed AG has a market cap or net worth of €67.97 thousand as of January 9, 2026. Its market cap has decreased by -95.39% in one year.
Market Cap
67.97K
Enterprise Value
125.97K
Revenue
20.49K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.05
Market Cap Chart
Since December 13, 2006, bioXXmed AG's market cap has decreased from 16.12M to 67.97K, a decrease of -99.58%. That is a compound annual growth rate of -24.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 67.97K | 127.27% |
| Dec 30, 2025 | 29.91K | -95.56% |
| Dec 30, 2024 | 673.01K | -88.20% |
| Dec 30, 2022 | 5.70M | -69.02% |
| Dec 30, 2021 | 18.41M | -70.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |